Significance of breast lesion descriptors in the ACR BI-RADS MRI lexicon

Cancer

Volumn 115, Issue 7, 2009, Pages 1363-1380

  Agrawal, G ^a,b   Su, M Y ^a   Nalcioglu, O ^a   Feig, S A ^c   Chen, J H ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

BI RADS MRI lexicon; Breast cancer; Breast lesions; Breast MRI; DCE MRI

Indexed keywords

BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR;

ANGIOGENESIS; BREAST BIOPSY; BREAST IMAGING REPORTING AND DATA SYSTEM; BREAST LESION; CANCER CLASSIFICATION; CLINICAL PROTOCOL; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; EVALUATION; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; MEDICAL PRACTICE; MORPHOLOGY; NON PROFIT ORGANIZATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW; STANDARDIZATION;

BREAST DISEASES; BREAST NEOPLASMS; DICTIONARIES, MEDICAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; TERMINOLOGY AS TOPIC;

EID: 63449120748     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24156     Document Type: Review

References (106)

1. Grady D. Much wider use of M.R.I.'s urged for breast exam. The New York Times. March 28, 2007, Health section. Available at: http://query.nytimes.com/ gst/fullpage. html?res=9E0DE2DA1330F93BA15750C0A9619C8B63&sec =&spon=&pagewanted=all. Accessed on April 21, 2008.
2. Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57:75-89.
3. Tillman GF, Orel SG, Schnall MD, et al. Effect of breast magnetic resonance imaging on the clinical management of women with early-stage breast carcinoma. J Clin Oncol. 2002;20:3413-3423.
4. Bedrosian I, Mick R, Orel SG, et al. Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer. 2003;98:468-473.
5. Hylton N. Magnetic resonance imaging of the breast: opportunities to improve breast cancer management. J Clin Oncol. 2005;23:1678-1684.
6. Braun M, Polcher M, Schrading S, et al. Influence of pre- operative MRI on the surgical management of patients with operable breast cancer. Breast Cancer Res Treat. 2008;111:179-187.
7. Kuhl CK, Schrading S, Leutner CC, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol. 2005;23:8469-8476.
8. Lehman CD, GatsonisC,KuhlCK, et al.MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med. 2007;356:1295-1303.
9. Schelfout K, Van Goethem M, Kersschot E, et al. Contrast-enhanced MR imaging of breast lesions and effect on treatment. Eur J Surg Oncol. 2004;30:501-507.
10. Zhang Y, Fukatsu H, Naganawa S, et al. The role of contrast-enhanced MR mammography for determining candidates for breast conservation surgery. Breast Cancer. 2002;9:231-239.
11. Esserman L, Hylton N, Yassa L, et al. Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J Clin Oncol. 1999;17:110-119.
12. Beatty JD, Porter BA. Contrast-enhanced breast magnetic resonance imaging: the surgical perspective. Am J Surg. 2007;193:600-605.
13. Pediconi F, Catalano C, Padula S, et al. Contrast-enhanced magnetic resonance mammography: does it affect surgical decision-making in patients with breast cancer? Breast Cancer Res Treat. 2007;106:65-74.
14. Kuhl CK, Schrading S, Bieling HB, et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet. 2007;370:485-492.
15. American College of Radiology. Breast Imaging Reporting and Data System (BI-RADS). 4th ed. Reston, Va: American College of Radiology; 2003.
16. Schnall MD, Ikeda DM. Lesion Diagnosis Working Group report. J Magn Reson Imaging. 1999;10:982-990.
17. Ikeda DM, Baker DR, Daniel BL. Magnetic resonance imaging of breast cancer: clinical indications and breast MRI reporting system. J Magn Reson Imaging. 2000;12:975-983.
18. Morris EA. Breast MR imaging lexicon updated. Magn Reson Imaging Clin N Am. 2006;14:293-303.
19. Balleyguier C, Ayadi S, Van Nguyen K, et al. BIRADS classification in mammography. Eur J Radiol. 2007;61:192-194.
20. Ikeda DM, Hylton NM, Kinkel K, et al. Development, standardization, and testing of a lexicon for reporting contrast-enhanced breast magnetic resonance imaging studies. J Magn Reson Imaging. 2001;13:889-895.
21. Schnall MD, Rosten S, Englander S, et al. A combined architectural and kinetic interpretation model for breast MR images. Acad Radiol. 2001;8:591-597.
22. Kinkel K, Helbich TH, Esserman LJ, et al. Dynamic high- spatial-resolution MR imaging of suspicious breast lesions: diagnostic criteria and interobserver variability. AJR Am J Roentgenol. 2000;175:35-43.
23. Nunes LW, Schnall MD, Orel SG. Update of breast MR imaging architectural interpretation model. Radiology. 2001;219:484-494.
24. Liberman L, Morris EA, Lee MJ, et al. Breast lesions detected on MR imaging: features and positive predictive value. AJR Am J Roentgenol. 2002;179:171-178.
25. U.S. Department of Health and Human Services, Food and Drug Administration Web site. Criteria for significant risk investigations of magnetic resonance diagnostic devices [document 793]. Available at:http://www.fda.gov/cdrh/ode/guidance/793.html. Accessed May 12, 2008.
26. Kuhl CK. The current status ofbreast MR imaging. pt I. choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. Radiology. 2007;244:356-378.
27. Kuhl CK, Jost P, Morakkabati N, et al. Contrast-enhanced MR imaging of the breast at 3.0 and 1.5 T in the same patients: initial experience. Radiology. 2006;239:666-676.
28. Kuhl CK, Kooijman H, Gieseke J, Schild HH. Effect of B1 inhomogeneity on breast MR imaging at 3.0 T. Radiology. 2007;244:929-930.
29. Kuhl CK, Schild HH, Morakkabati N. Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution. Radiology. 2005;236:789-800.
30. Macura KJ, Ouwerkerk R, Jacobs MA, Bluemke DA. Patterns of enhancement on breast MR images: interpretation and imaging pitfalls. Radiographics. 2006;26:1719-1734.
31. Kuhl CK, Mielcareck P, Klaschik S, et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology. 1999;211:101-110.
32. Kaiser WA. Breast magnetic resonance imaging: principles and techniques. Semin Roentgenol. 2007;42:228-235.
33. Wenkel E, Geppert C, Schulz-Wendtland R, et al. Diffusion weighted imaging in breast MRI: comparison of 2 different pulse sequences. Acad Radiol. 2007;14:1077-1083.
34. Yoshikawa MI, Ohsumi S, Sugata S, et al. Comparison of breast cancer detection by diffusion-weighted magnetic resonance imaging and mammography. Radiat Med. 2007;25:218-223.
35. Park MJ, Cha ES, Kang BJ, et al. The role of diffusion- weighted imaging and the apparent diffusion coefficient (ADC) values for breast tumors. Korean J Radiol. 2007;8:390-396.
36. Sinha S, Lucas-Quesada FA, Sinha U, et al. In vivo diffusion-weighted MRI of the breast: potential for lesion characterization. J Magn Reson Imaging. 2002;15:693-704.
37. Stejskal EO, Tanner JE. Spin diffusion measurements: spin echoes in the presence of a time dependent field gradient. J Chem Phys. 1965;42:288-292.
38. Woodhams R, Matsunaga K, Iwabuchi K, et al. Diffusion- weighted imaging of malignant breast tumors: the usefulness of apparent diffusion coefficient (ADC) value and ADC map for the detection of malignant breast tumors and evalution of cancer extension. J Comput Assist Tomogr. 2005;29:644-649.
39. Guo Y, Cai YQ, Cai ZL, et al. Differentiation of clinically benign and malignant breast lesions using diffusion- weighted imaging. J Magn Reson Imaging. 2002;16:172-178.
40. Kinoshita T, Yashiro N, Ihara N, et al. Diffusion- weighted half-fourier single-shot turbo spin echo imaging in breast tumors: differentiation of invasive ductal carcinoma from fibroadenoma. J Comput Assist Tomogr. 2002;26:1042-1046.
41. Marini C, Iacconi C, Giannelli M, et al. Quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesion. Eur Radiol. 2007;17:2646-2655.
42. Rubesova E, Grell AS, De Maertelaer V, et al. Quantitative diffusion imaging in breast cancer: a clinical prospective study. JMagn Reson Imaging. 2006;24:319-324.
43. Kuhl CK. Concepts for differential diagnosis in breast MR imaging. Magn Reson Imaging Clin N Am. 2006;14:305-328.
44. Muller-Schimpfle M, Ohmenhauser K, Stoll P, et al. Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast. Radiology. 1997;203:145-149.
45. Kuhl CK, Bieling HB, Gieseke J, et al. Healthy premeno- pausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. Radiology. 1997;203:137-144.
46. Morris EA. The normal breast. In: Morris EA, Liberman L, eds. Breast MRI Diagnosis and Intervention. 1st ed. Secaucus, NJ: Springer-Verlag; 2005:23-44.
47. Buadu LD, Murakami J, Murayama S, et al. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angio-genesis. Radiology. 1996;200:639-649.
48. Yasumura K, Ogawa K, Yuasa Y, et al. Dynamic MRI and tumor angiogenesis of breast cancer. Nippon Igaku Hoshasen Gakkai Zasshi. 2000;60:379-388.
49. Hulka CA, Smith BL, Sgroi DC, et al. Benign and malignant breast lesions: differentiation with echo-planar MR imaging. Radiology. 1995;197:33-38.
50. Tuncbilek N, Unlu E, Karakas HM, et al. Evaluation of tumor angiogenesis with contrast-enhanced dynamic magnetic resonance mammography. Breast J. 2003;9:403-408.
51. Narisada H, Aoki T, Sasaguri T, et al. Correlation between numeric gadolinium-enhanced dynamic MRI ratios and prognostic factors and histologic type of breast carcinoma. AJR Am JRoentgenol. 2006;187:297-306.
52. Teifke A, Behr O, Schmidt M, et al. Dynamic MR imaging of breast lesions: correlation with microvessel distribution pattern and histologic characteristics of prognosis. Radiology. 2006;239:351-360.
53. Oshida K, Nagashima T, Ueda T, et al. Pharmacokinetic analysis of ductal carcinoma in situ of the breast using dynamic MR mammography. Eur Radiol. 2005;15:1353-1360.
54. Tse GM, Chaiwun B, Wong KT, et al. Magnetic resonance imaging of breast lesions-a pathologic correlation. Breast Cancer Res Treat. 2007;103:1-10.
55. Matsubayashi R, Matsuo Y, Edakuni G, et al. Breast masses with peripheral rim enhancement on dynamic contrast- enhanced MR images: correlation of MR findings with histologic features and expression of growth factors. Radiology. 2000;217:841-848.
56. Turetschek K, Preda A, Floyd E, et al. MRI monitoring of tumor response following angiogenesis inhibition in an experimental human breast cancer model. Eur J Nucl Med Mol Imaging. 2003;30:448-455.
57. Fournier LS, Novikov V, Lucidi V, et al. MR monitoring of cyclooxygenase-2 inhibition of angiogenesis in a human breast cancer model in rats. Radiology. 2007;243:105-111.
58. Wilmes LJ, Pallavicini MG, Fleming LM, et al. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging. Magn Reson Imaging. 2007;25:319-327.
59. Schnall MD, Blume J, Bluemke DA, et al. Diagnostic architectural and dynamic features at breast mr imaging: mul- ticenter study. Radiology. 2006;238:42-53.
60. Goto M, Ito H, Akazawa K, et al. Diagnosis of breast tumors by contrast-enhanced MR imaging: comparison between the diagnostic performance of dynamic enhancement patterns and morphologic features. J Magn Reson Imaging. 2007;25:104-112.
61. Nunes LW, Schnall MD, Orel SG, et al. Breast MR imaging: interpretation model. Radiology. 1997;202:833-841.
62. Nunes LW, Schnall MD, Siegelman ES, et al. Diagnostic performance characteristics of architectural features revealed by high spatial-resolution MR imaging of the breast. AJR Am JRoentgenol. 1997;169:409-415.
63. Nunes LW, Schnall MD, Orel SG, et al. Correlation of lesion appearance and histologic findings for the nodes of a breast MR imaging interpretation model. Radiographics. 1999;19:79-92.
64. Tozaki M, Igarashi T, Matsushima S, Fukuda K. High- spatial-resolution MR imaging of focal breast masses: interpretation model based on kinetic and morphological parameters. Radiat Med. 2005;23:43-50.
65. Hochman MG, Orel SG, Powell CM, et al. Fibroadenomas: MR imaging appearances with radiologic-histopathologic correlation. Radiology. 1997;204:123-129.
66. Tozaki M, Igarashi T, Fukuda K. Positive and negative predictive values of BI-RADS-MRI descriptors for focal breast masses. Magn Reson Med Sci. 2006;5:7-15.
67. Orel SG. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology. 1995;196:115-122.
68. Chen JH, Agrawal G, Feig B, et al. Triple negative breast cancer: MR imaging features in 29 patients. Ann Oncol. 2007;18:2042-2043.
69. Agrawal G, Chen JH, Baik HM, et al. MR imaging features of breast cancer: a correlation study with HER-2 receptor. Ann Oncol. 2007;18:1903-1904.
70. Chen JH, Baek HM, Nalcioglu O, Su MY. Estrogen receptor and breast MR imaging features: a correlation study. J Magn Reson Imaging.. 2008;27:825-833.
71. Wurdinger S, Herzog AB, Fischer DR, et al. Differentiation of phyllodes breast tumors from fibroadenomas on MRI. AJR Am J Roentgenol. 2005;185:1317-1321.
72. Onishi M, Furukawa A, Takahashi M, Murata K. A wide variety of dynamic contrast-enhanced MR appearances of breast cancer: Pathologic correlation study. Eur J Radiol. 2008;65:286-292.
73. Jinguji M, Kajiya Y, Kamimura K, et al. Rim enhancement of breast cancers on contrast-enhanced MR imaging: relationship with prognostic factors. Breast Cancer. 2006;13:64-73.
74. Chen JH, Nalcioglu O, Su MY. Fibrocystic change of the breast presenting as a focal lesion mimicking breast cancer in MR imaging. J Magn Reson Imaging. 200828:1499-1505.
75. Liberman L, Mason G, Morris EA, Dershaw DD. Does size matter? Positive predictive value of MRI-detected breast lesions as a function of lesion size. AJR Am J Roentgenol. 2006;186:426-430.
76. Chen JH, Liu H, Baek HM, Nalcioglu O, Su MY. Magnetic resonance imaging features of fibrocystic change of the breast. Magn Reson Imaging. 2008;26:1207-1214.
77. Liberman L, Morris EA, Dershaw DD, et al. Ductal enhancement on MR imaging of the breast. AJR Am J Roentgenol. 2003;181:519-525.
78. Van Goethem M, Schelfout K, Kersschot E, et al. Comparison of MRI features of different grades of DCIS and invasive carcinoma of the breast. JBR-BTR. 2005;88:225-232.
79. Menell JH, Morris EA, Dershaw DD, et al. Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging. Breast J. 2005;11:382-390.
80. Tozaki M, Fukuda K. High-spatial-resolution MRI of non- masslike breast lesions: interpretation model based on BIRADS MRI descriptors. AJR Am J Roentgenol. 2006;187: 330-337.
81. Tozaki M, Igarashi T, Fukuda K. Breast MRI using the VIBE sequence: clustered ring enhancement in the differential diagnosis of lesions showing non-masslike enhancement. AJR Am J Roentgenol. 2006;187:313-321.
82. Morakkabati-Spitz N, Leutner C, Schild H, et al. Diagnostic usefulness of segmental and linear enhancement in dynamic breast MRI. Eur Radiol. 2005;15:2010-2017.
83. van den Bosch MA, Daniel BL, Mariano MN, et al. Magnetic resonance imaging characteristics of fibrocystic change of the breast. Invest Radiol. 2005;40:436-441.
84. Qayyum A, Birdwell RL, Daniel BL, et al. MR imaging features of infiltrating lobular carcinoma of the breast: histopathologic correlation. AJR Am J Roentgenol. 2002;178:1227-1232.
85. Capobianco G, Spaliviero B, Dessole S, et al. Paget's disease of the nipple diagnosed by MRI. Arch Gynecol Obstet. 2006;274:316-318.
86. Frei KA, Bonel HM, Pelte MF, et al. Paget disease of the breast: findings at magnetic resonance imaging and histopathologic correlation. Invest Radiol. 2005;40:363-367.
87. Morris EA, Schwartz LH, Drotman MB, et al. Evaluation of pectoralis major muscle in patients with posterior breast tumors on breast MR images: early experience. Radiology. 2000;214:67-72.
88. Egan RL, McSweeney MB. Intramammary lymph nodes. Cancer. 1983;51:1838-1842.
89. Stomper PC, Leibowich S, Meyer JE. The prevalence and distribution of well-circumbscribed nodules on screening mammography: analysis of 1500 mammograms. Breast Dis. 1991;4:197-203.
90. Svane G, Franzen S. Radiologic appearance of nonpalpable intramammary lymph nodes. Acta Radiol. 1993;34:577-580.
91. Memarsadeghi M, Riedl CC, Kaneider A, et al. Axillary lymph node metastases in patients with breast carcinomas: assessment with nonenhanced versus uspio-enhanced MR imaging. Radiology. 2006;241:367-377.
92. Kuhl CK. Current status of breast MR imaging. pt 2. clinical applications. Radiology. 2007;244:672-691.
93. Bluemke DA, Gatsonis CA, Chen MH, et al. Magnetic resonance imaging of the breast prior to biopsy. JAMA. 2004;292:2735-2742.
94. Luciani A, Dao TH, Lapeyre M, et al. Simultaneous bilateral breast and high-resolution axillary MRI of patients with breast cancer: preliminary results. AJR Am J Roent- genol. 2004;182:1059-1067.
95. Michel SC, Keller TM, Frohlich JM, et al. Preoperative breast cancer staging: MR imaging of the axilla with ultra- small superparamagnetic iron oxide enhancement. Radiology. 2002;225:527-536.
96. Szabo BK, Aspelin P, Wiberg MK, Bone B. Dynamic MR imaging of the breast. Analysis of kinetic and morphologic diagnostic criteria. Acta Radiol. 2003;44:379-386.
97. Orel S. Who should have breast magnetic resonance imaging evaluation? J Clin Oncol. 2008;26:703-711.
98. Heywang-Kobrunner SH, Huynh AT, Viehweg P, et al. Prototype breast coil for MR-guided needle localization. J Comput Assist Tomogr. 1994;18:876-881.
99. Orel SG, Schnall MD, Newman RW, et al. MR imaging-guided 9-gauge vacuum-assisted core-needle breast biopsy: initial experience. Radiology. 1994;193:97-102.
100. Kuhl CK, Elevelt A, Leutner CC, et al. Interventional breast MR imaging: clinical use of a stereotactic localization and biopsy device. Radiology. 1997;204:667-675.
101. Liney GP, Tozer DJ, van Hulten HB, et al. Bilateral open breast coil and compatible intervention device. J Magn Reson Imaging. 2000;12:984-990.
102. Daniel BL, Birdwell RL, Black JW, et al. Interactive MR- guided, 14-gauge core-needle biopsy of enhancing lesions in a breast phantom mode. Acad Radiol. 1997;4:508-512.
103. Daniel BL, Birdwell RL, Ikeda DM, et al. Breast lesion localization: a freehand, interactive MR imaging-guided technique. Radiology. 1998;207:455-463.
104. Perlet C, Heywang-Kobrunner SH, Heinig A, et al. Magnetic resonance-guided, vacuum-assisted breast biopsy: results from a European multicenter study of 538 lesions. Cancer. 2006;106:982-990.
105. Heywang-Kobrunner SH, Heinig A, Schaumloffel U, et al. MR-guided percutaneous excisional and in- cisional biopsy of breast lesions. Eur Radiol. 1999;9: 1656-1665.
106. Tardivon AA, Athanasiou A, Thibault F, El Khoury C. Breast imaging and reporting data system (BIRADS) magnetic resonance imaging illustrated cases. Eur J Radiol. 2007;61:216-223.